Sysmex Releases the In Vitro Diagnostics Industry’s First Coagulation Analyzer with a Multi-Wavelength Pre-Analytical Check, the CS-2000 i

- Measuring parameters related to cerebral infarction and other types of thrombosis and improving testing efficiency -

Aug 30 , 2006 - Sysmex Corporation (HQ: Kobe, Japan; President: Hisashi Ietsugu) announced today the release of its next-generation blood coagulation analyzer, the CS-2000 i, which features the in vitro diagnostics industry’s first coagulation analyzer with a multi-wavelength pre-analytical check. Being the leading instrument manufacturer in the coagulation field, we expect that this new offering will help to improve the efficiency and quality of coagulation tests.

Coagulation tests check the important physiological mechanism known as “hemostasis”. Using plasma (a component of blood) as a sample, these tests are performed for the screening and diagnosis of hemophilia and thrombosis by investigating bleeding tendency (impaired blood clotting) and thrombosis tendency (formation of blood clots).

Equipped with an optical fiber that supplies light at five wavelengths and a detector capable of receiving light in multiple wavelengths (multi-wavelength detection), the CS-2000 i is able to simultaneously measure multiple parameters. Each detector channel simultaneously measures at multiple wavelengths. All measurement technologies can be measured in each channel and since dedicated detector channels are not required for each of these technologies, this coagulation analyzer reduces the time required to measure one sample and improves throughput.

In addition, a pre-analytical check for interfering substances in the sample (hemolysis, icterus, lipemia) using Sysmex’s new multi-wavelength technology is performed prior to any testing. The CS-2000 i makes adjustments according to the result of the check, thus further reducing testing time and the need for retests.

Although it was designed primarily for mid-sized laboratories, the CS-2000 i supports a list of parameters equivalent to that of current high-end models. Capable of performing the tests necessary for screening, diagnosis and treatment of several types of thrombosis, including cerebral infarction and myocardial infarction (cases of which are increasing in developed countries as their societies age), this analyzer is expected to facilitate the management of thrombosis.

When connected to SNCS (Sysmex Network Communication System), the CS-2000 i offers online support and remote quality control services from our Customer Support Center in Kobe, Japan. The user interface comes with a touch panel for easy test data management and instrument control.

The size of the global coagulation market is estimated to be roughly ¥120 billion (company estimate). Having signed an agreement in 1995 for collaboration in selling coagulation product lines with Dade Behring Inc., the world’s largest manufacturer of coagulation reagents, Sysmex now holds the number one position in the global coagulation analyzer market.

Product specifications were developed through a joint project with Dade Behring who intends to commercialize the instrument at a later date. “CS” stands for “Coagulation Station”, in the hope that it will become a new platform for a variety of coagulation tests at the various stages from screening to recurrence prevention.

We are planning to expand the line of the CS series, with a view towards expanding business opportunities in coagulation testing, as well as standardizing and improving the quality of the coagulation testing process.


1.Name: Automated Blood Coagulation Analyzer CS-2000 i
2.Launch: Japan – August 2006, outside of Japan – November 2006 and after
3.Target market: global. Timing of launch within the territories where Dade Behring assumes marketing responsibility shall be determined by Dade Behring.

***
Information contained in the press release is
current as of the date of the announcement,
but may be subject to change without prior notice.

Contact Information

Head Office

Sysmex Corporation

Contact via E-mail